Sarah Zielsdorf, MD, MS – Attenuating Viral Pathogenesis with TLR and VitD Receptor Therapeutics – 2022 Conference (LDN; low dose naltrexone)
Sarah Zielsdorf, MD, MS – Attenuating Viral Pathogenesis with TLR and VitD Receptor Therapeutics – 2022 Conference (LDN; low dose naltrexone)